Physician profile
Brian Michael Roth
NPI 1659346567
$1,175.04
in general payments reported to CMS, 2019-2025
17 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.35 · 2020: $109 · 2021: $91.27 · 2022: $121 · 2023: $401 · 2024: $233 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Education: $26.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.20 |
| Education | $26.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.19 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Otsuka America Pharmaceutical, INC. | $165.12 | 2023 | Nuedexta |
| Allergan, INC. | $127.84 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $60.87 | 2021-2024 | Xeomin |
| Horizon Therapeutics Plc | $56.73 | 2019-2021 | |
| Pacira Therapeutics, INC. | $53.76 | 2019 | |
| Averitas Pharma INC. | $49.66 | 2023-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $39.79 | 2025 | |
| Nevro Corp. | $30.48 | 2023 | Senza |
| Otto Bock Healthcare Lp | $26.61 | 2024 | |
| Grt US Holding, INC. | $24.92 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $23.53 | 2023 | Ztlido |
| Merz North America, INC. | $21.96 | 2019 | |
| Collegium Pharmaceutical, INC. | $20.36 | 2023 | Belbuca |
| Pfizer INC. | $19.27 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Rehabilitative Sciences, INC | $14.59 | 2024 | Rs 4i Plus Sequential Stimulator |
| Ferring Pharmaceuticals INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.